April 19 (Reuters) – Eli Lilly is in advanced talks to acquire Kelonia Therapeutics for more than $2 billion, the Wall Street Journal reported on Sunday.
Reuters could not immediately verify the report.
(Reporting by Mihika Sharma in Bengaluru; Editing by Lisa Shumaker)
Brought to you by www.srnnews.com